Kyverna Therapeutics, Inc.
KYTX
$7.66
-$0.19-2.42%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
6/8/2026
-
Nasdaq News: Markets
Kyverna Therapeutics vs. Vertex Pharmaceuticals: Which Drug Developer Stock Is a Better Buy in 2026?
6/8/2026
-
Fool.com Headlines
6/3/2026
-
Globe Newswire
6/2/2026
-
TipRanks Financial Blog
5/26/2026
-
TipRanks Financial Blog
5/18/2026
-
TipRanks Financial Blog
5/18/2026
-
Nasdaq News: Markets
5/18/2026
-
Seeking Alpha - Healthcare
5/18/2026
-
Globe Newswire
5/14/2026
-
Globe Newswire
5/13/2026
-
TipRanks Financial Blog
5/13/2026
-
TipRanks Financial Blog
5/12/2026
-
Globe Newswire
5/12/2026
-
FierceBiotech.com - Biotech
5/7/2026
-
MarketBeat
5/6/2026
-
MarketBeat
5/5/2026
-
MarketBeat
5/5/2026
-
FiercePharma
5/4/2026
-
Globe Newswire
5/2/2026
-
MarketBeat
4/25/2026
-
MarketBeat
4/24/2026
-
MarketBeat
4/23/2026
-
Ticker Report
4/23/2026
-
MarketBeat
4/22/2026
-
Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 12, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
510 925 2492
Address
5980 Horton Street
Emeryville, CA 94608
Emeryville, CA 94608
Country
Year Founded
Business Description
Sector
Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an...
more